Baynes Roy D. 4

Accession 0001680739-25-000007

CIK 0001604821other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 8:05 PM ET

Size

29.7 KB

Accession

0001680739-25-000007

Insider Transaction Report

Form 4

Period: 2025-11-19

Natera, Inc.NTRA

Baynes Roy D.

Director

Transactions

Exercise/Conversion
Stock Option (right to buy)
2025-11-20−600→ 0 total
Exercise: $40.93Exp: 2030-06-11→ Common Stock (600 underlying)
Exercise/Conversion
Common Stock
2025-11-20$41.19/sh+7,068$291,131→ 26,027 total
Sale
Common Stock
2025-11-20$224.89/sh−1,884$423,685→ 18,359 total
Exercise/Conversion
Stock Option (right to buy)
2025-11-19−5,112→ 600 total
Exercise: $40.93Exp: 2030-06-11→ Common Stock (5,112 underlying)
Exercise/Conversion
Common Stock
2025-11-20$40.93/sh+600$24,558→ 18,959 total
Sale
Common Stock
2025-11-20$220.14/sh−1,184$260,646→ 24,843 total
Sale
Common Stock
2025-11-20$223.90/sh−1,900$425,417→ 20,243 total
Exercise/Conversion
Stock Option (right to buy)
2025-11-20−7,068→ 0 total
Exercise: $41.19Exp: 2032-05-25→ Common Stock (7,068 underlying)
Sale
Common Stock
2025-11-19$213.47/sh−1,250$266,839→ 22,221 total
Sale
Common Stock
2025-11-19$216.07/sh−2,135$461,304→ 18,359 total
Sale
Common Stock
2025-11-20$221.81/sh−900$199,632→ 23,943 total
Exercise/Conversion
Common Stock
2025-11-19$40.93/sh+5,112$209,234→ 23,471 total
Sale
Common Stock
2025-11-19$214.79/sh−1,727$370,946→ 20,494 total
Sale
Common Stock
2025-11-20$222.90/sh−1,800$401,220→ 22,143 total

Footnotes (10)

[F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025.
[F10]The option shares are fully exercisable.
[F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.18 to $214.1550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.35 to $215.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.55 to $216.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.42 to $222.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F7]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.46 to $223.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F8]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.49 to $224.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F9]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.72 to $224.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

4
form4-11212025_081101.xmlPrimary

Issuer

Natera, Inc.

CIK 0001604821

→

Entity typeother

Related Parties

filerCIK 0001680739

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 8:05 PM ET
Size: 29.7 KB

View on SEC.gov